Stocks · Health care · Pharmaceutical Preparations

Stoke Therapeutics, Inc.

STOK Clue Score65
United States Fiscal year ends December CIK 0001623526 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
ATP Life Science Ventures, L.P.
24 Nov 2020
10% owner
Buy
375,000
$39.00
$14.63M
Seth Loring Harrison
24 Nov 2020
Director
Buy indirect
375,000
$39.00
$14.63M
Showing 250 of 267 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 276
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 75
Sales straight out of an exercise 96
Sales at will 77
Transactions with no price 0
Shares from compensation/vesting 53,171,597
Sales filed before the plan box existed 15
History held since 20 Jun 2019